论文信息 - Afatinib combined with anti-PD1 enhances immunotherapy of hepatocellular carcinoma via ERBB2/STAT3/PD-L1 signaling - 字舞流文

Afatinib combined with anti-PD1 enhances immunotherapy of hepatocellular carcinoma via ERBB2/STAT3/PD-L1 signaling

Chao Pan | Min Wang | Yong Ma | Xinyi Zhang | Xinyi Zhang | Longcheng Shang | Yong Ma | Weijun Yang | Siqi Zhao | Weijun Yang | Jin Zhou | Jin Zhou | Chao Yu | Gaoxin Xu | Yongheng Feng | Min Wang